Metabolomic Insights into COVID-19 Severity: A Scoping Review
Open Access
- 12 November 2024
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 14 (11) , 617
Abstract
Background: In 2019, SARS-CoV-2, the novel coronavirus, entered the world scene, presenting a global health crisis with a broad spectrum of clinical manifestations. Recognizing the significance of metabolomics as the omics closest to symptomatology, it has become a useful tool for predicting clinical outcomes. Several metabolomic studies have indicated variations in the metabolome corresponding to different disease severities, highlighting the potential of metabolomics to unravel crucial insights into the pathophysiology of SARS-CoV-2 infection. Methods: The PRISMA guidelines were followed for this scoping review. Three major scientific databases were searched: PubMed, the Directory of Open Access Journals (DOAJ), and BioMed Central, from 2020 to 2024. Initially, 2938 articles were identified and vetted with specific inclusion and exclusion criteria. Of these, 42 articles were retrieved for analysis and summary. Results: Metabolites were identified that were repeatedly noted to change with COVID-19 and its severity. Phenylalanine, glucose, and glutamic acid increased with severity, while tryptophan, proline, and glutamine decreased, highlighting their association with COVID-19 severity. Additionally, pathway analysis revealed that phenylalanine, tyrosine and tryptophan biosynthesis, and arginine biosynthesis were the most significantly impacted pathways in COVID-19 severity. Conclusions: COVID-19 severity is intricately linked to significant metabolic alterations that span amino acid metabolism, energy production, immune response modulation, and redox balance.Keywords
Funding Information
- Lung Association, Alberta
- NWT (National Grant Review program)
- University of Calgary
- Fluidome, Inc.
This publication has 56 references indexed in Scilit:
- Plasma metabolomic characterization of SARS-CoV-2 Omicron infectionCell Death & Disease, 2023
- Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19iScience, 2022
- 1H qNMR-Based Metabolomics Discrimination of Covid-19 SeverityJournal of Proteome Research, 2022
- Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcomeMetabolomics, 2021
- Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severityCell Reports Medicine, 2021
- Role of arachidonic cascade in COVID-19 infection: A reviewProstaglandins & Other Lipid Mediators, 2021
- Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot studyEBioMedicine, 2021
- SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggressionMedical Hypotheses, 2020
- What about COVID-19 and arachidonic acid pathway?European Journal of Clinical Pharmacology, 2020
- A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individualsNature Communications, 2019